Integrated SARS-CoV-2 serological and virological screening across an acute fever surveillance platform to monitor temporal changes in anti-spike antibody levels …
EJ Nilles, M de St. Aubin, D Dumas, W Duke… - medRxiv, 2022 - medrxiv.org
The global SARS-CoV-2 immune landscape and population protection against emerging
variants is largely unknown. We assessed SARS-CoV-2 antibody changes in the Dominican …
variants is largely unknown. We assessed SARS-CoV-2 antibody changes in the Dominican …
[HTML][HTML] Monitoring temporal changes in SARS-CoV-2 spike antibody levels and variant-specific risk for infection, Dominican Republic, March 2021–August 2022
To assess changes in SARS-CoV-2 spike binding antibody prevalence in the Dominican
Republic and implications for immunologic protection against variants of concern, we …
Republic and implications for immunologic protection against variants of concern, we …
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023
JM Carreno Quiroz, A Wagner, B Monahan, D Floda… - medRxiv, 2023 - medrxiv.org
Sero-monitoring provides context to the epidemiology of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections and changes in population immunity following …
coronavirus 2 (SARS-CoV-2) infections and changes in population immunity following …
Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and …
L Inchauste, E Nurtop, LB Machicado, YL Roth… - medRxiv, 2023 - medrxiv.org
Unlike genomic data, serological data have not been previously leveraged to evaluate the
SARS-CoV-2 variants circulation. In Bolivia, sustained genomic surveillance capacities were …
SARS-CoV-2 variants circulation. In Bolivia, sustained genomic surveillance capacities were …
[HTML][HTML] Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity
F Muecksch, H Wise, K Templeton, B Batchelor… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background Serological assays are being deployed to monitor antibody responses in SARS-
CoV-2 convalescents and vaccine recipients. There is a need to determine whether such …
CoV-2 convalescents and vaccine recipients. There is a need to determine whether such …
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New …
SK Greene, A Levin‐Rector, NTT Kyaw… - Influenza and Other …, 2023 - Wiley Online Library
Background Comparing disease severity between SARS‐CoV‐2 variants among
populations with varied vaccination and infection histories can help characterize emerging …
populations with varied vaccination and infection histories can help characterize emerging …
SARS-CoV-2 Serosurveys: How antigen, isotype and threshold choices affect the outcome
RA Binder, GF Fujimori, CS Forconi… - The Journal of …, 2023 - academic.oup.com
Background Evaluating the performance of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) serological assays and clearly articulating the utility of selected antigens …
(SARS-CoV-2) serological assays and clearly articulating the utility of selected antigens …
Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant
KK Riemersma, BE Grogan, A Kita-Yarbro, GE Jeppson… - MedRxiv, 2021 - medrxiv.org
Abstract SARS-CoV-2 variant B. 1.617. 2 (delta) is associated with higher viral loads and
increased transmissibility relative to other variants, as well as partial escape from polyclonal …
increased transmissibility relative to other variants, as well as partial escape from polyclonal …
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
NB Stærke, J Reekie, H Nielsen, T Benfield… - Nature …, 2022 - nature.com
SARS-CoV-2 variants of concern have continuously evolved and may erode vaccine
induced immunity. In this observational cohort study, we determine the risk of breakthrough …
induced immunity. In this observational cohort study, we determine the risk of breakthrough …
[HTML][HTML] Vaccine breakthrough infection with the SARS-CoV-2 Delta or Omicron (BA. 1) Variant leads to distinct profiles of neutralizing antibody responses
MS Seaman, MJ Siedner, J Boucau, CL Lavine… - medRxiv, 2022 - ncbi.nlm.nih.gov
There is increasing evidence that the risk of SARS-CoV-2 infection among vaccinated
individuals is variant-specific, suggesting that protective immunity against SARS-CoV-2 may …
individuals is variant-specific, suggesting that protective immunity against SARS-CoV-2 may …
相关搜索
- sars cov antibody levels
- sars cov risk for infection
- sars cov temporal changes
- risk for infection temporal changes
- serological assays antibody levels
- sars cov surveillance capabilities
- viral variants antibody levels
- sars cov viral variants
- sars cov serological assays
- sars cov prospective assessment
- hospitalization risk patient level
- sars cov high prevalence
- sars cov blood donors
- sars cov patient level
- sars cov antibody responses
- sars cov hospitalization risk